Pharmacists in Minot Afb, ND Accepting Medicare
6 Pharmacists found. Showing 1 - 6
 Dr. Elaine W. Sit, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10 Missile Ave, Minot Afb, ND 58705 Phone: 701-723-5296 |
Ms. Christi Lynn Smith, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 194 Missile Ave, Minot Afb, ND 58704 Phone: 701-723-5294 |
 Mr. Daniel John Heser, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10 Missle Ave, Minot Afb, ND 58705 Phone: 701-723-5294 Fax: 701-723-5302 |
Adewale Ajulo, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 194 Missile Ave, 5th Medical Group, Minot Afb, ND 58705 Phone: 701-723-5296 |
Mr. Scott Edward Olech, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10 Missile Ave, Minot Afb, ND 58705 Phone: 701-723-5294 |
Dr. Sarah Jane Slagle, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10 Missle Ave, Minot Afb, ND 58705 Phone: 701-723-5296 |
News Archive
OGT releases new application note detailing performance of two DNA labelling kits
Oxford Gene Technology, The Molecular Genetics Company, has released a new application note detailing the technical evaluation of two DNA labelling kits, where OGT's CytoSure Genomic DNA Labelling Kits were found to be quicker and more accurate than a leading alternative.
Eli Lilly, Synthes collaborate to develop osteoinductive products
Synthes, Inc. and Eli Lilly and Company today announced the signing of an exclusive worldwide collaboration agreement to address the needs of patients who are cared for by orthopedic surgeons, including those with osteoporosis and those with bone fractures.
Study finds 18% increase in HIV treatment success rates
Researchers have been successful in increasing HIV treatment success rates by almost 18 percent.
New microRNA mechanism for regulating brain function
Non-coding regions of the genome - those that don't code for proteins - are now known to include important elements that regulate gene activity. Among those elements are microRNAs, tiny, recently discovered RNA molecules that suppress gene expression.
NOXXON Pharma announces the successful completion of the first phase I trial of Spiegelmer NOX-E36
NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, today announced successful completion of the first phase I trial with its anti-inflammatory Spiegelmer® NOX-E36. This drug candidate will be developed for the treatment of complications of type 2 diabetes, preferentially diabetic nephropathy, but also others.
› Verified 3 days ago
Clinical Social Workers
Dentists
Pharmacists
Psychologists
Counselors